Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Brexanolone by Sage Therapeutics for Tinnitus: Likelihood of Approval
Brexanolone is under clinical development by Sage Therapeutics and currently in Phase II for Tinnitus. According to GlobalData, Phase II...
Brexanolone by Lipocine for Post Partum Depression (Maternal Depression / Postnatal Depression): Likelihood of Approval
Brexanolone is under clinical development by Lipocine and currently in Phase III for Post Partum Depression (Maternal Depression / Postnatal...
Brexanolone by Sage Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Post-Traumatic Stress Disorder (PTSD). According to...
Brexanolone by Sage Therapeutics for Alcohol Dependence: Likelihood of Approval
Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Alcohol Dependence. According to GlobalData, Phase...
Brexanolone by Seaport Therapeutics for Major Depressive Disorder: Likelihood of Approval
Brexanolone is under clinical development by Seaport Therapeutics and currently in Phase II for Major Depressive Disorder. According to GlobalData,...
Brexanolone by NeuTherapeutics for Parkinson's Disease: Likelihood of Approval
Brexanolone is under clinical development by NeuTherapeutics and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...